{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T15:14:25Z","timestamp":1778944465439,"version":"3.51.4"},"reference-count":25,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2010,2,1]],"date-time":"2010-02-01T00:00:00Z","timestamp":1264982400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Lung Cancer"],"published-print":{"date-parts":[[2010,2]]},"DOI":"10.1016\/j.lungcan.2009.03.031","type":"journal-article","created":{"date-parts":[[2009,5,6]],"date-time":"2009-05-06T08:23:40Z","timestamp":1241598220000},"page":"194-197","source":"Crossref","is-referenced-by-count":73,"title":["Efficacy of chemotherapy with carboplatin and paclitaxel for unresectable thymic carcinoma"],"prefix":"10.1016","volume":"67","author":[{"given":"Satoshi","family":"Igawa","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haruyasu","family":"Murakami","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toshiaki","family":"Takahashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yukiko","family":"Nakamura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Asuka","family":"Tsuya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tateaki","family":"Naito","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kyoichi","family":"Kaira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akira","family":"Ono","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takehito","family":"Shukuya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akihiro","family":"Tamiya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masahiro","family":"Endo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nobuyuki","family":"Yamamoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.lungcan.2009.03.031_bib1","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1016\/S0022-5223(94)70112-1","article-title":"Thymic carcinoma. Ten years\u2019 experience in twenty patients","volume":"107","author":"Hsu","year":"1994","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10.1016\/j.lungcan.2009.03.031_bib2","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1002\/1097-0142(19910215)67:4<1025::AID-CNCR2820670427>3.0.CO;2-F","article-title":"Thymic carcinoma. A clinicopathologic study of 60 cases","volume":"67","author":"Suster","year":"1991","journal-title":"Cancer"},{"key":"10.1016\/j.lungcan.2009.03.031_bib3","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1097\/00000478-198210000-00003","article-title":"Primary thymic carcinomas","volume":"6","author":"Wick","year":"1982","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.lungcan.2009.03.031_bib4","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1016\/S0003-4975(03)00555-1","article-title":"Therapy for thymic epithelial tumors: a clinical study of 1,320 patients from Japan","volume":"76","author":"Kondo","year":"2003","journal-title":"Ann Thorac Surg"},{"key":"10.1016\/j.lungcan.2009.03.031_bib5","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1016\/S0003-4975(03)00831-2","article-title":"Thymic carcinoma: involvement of great vessels indicates poor prognosis","volume":"76","author":"Tseng","year":"2003","journal-title":"Ann Thorac Surg"},{"key":"10.1016\/j.lungcan.2009.03.031_bib6","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1097\/00000421-200206000-00012","article-title":"Chemotherapy for advanced thymic carcinoma: clinical response to cisplatin, doxorubicin, vincristine, and cyclophosphamide (ADOC chemotherapy)","volume":"25","author":"Koizumi","year":"2002","journal-title":"Am J Clin Oncol"},{"key":"10.1016\/j.lungcan.2009.03.031_bib7","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1002\/cncr.11606","article-title":"Weekly chemotherapy with cisplatin, vincristine, doxorubicin, and etoposide is an effective treatment for advanced thymic carcinoma","volume":"98","author":"Yoh","year":"2003","journal-title":"Cancer"},{"key":"10.1016\/j.lungcan.2009.03.031_bib8","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1200\/JCO.1992.10.1.16","article-title":"A phase II study of CPT-11, a new derivative of camptothecin, for previously untreated non-small-cell lung cancer","volume":"10","author":"Fukuoka","year":"1992","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.lungcan.2009.03.031_bib9","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1056\/NEJM199504133321507","article-title":"Paclitaxel (taxol)","volume":"332","author":"Rowinsky","year":"1995","journal-title":"N Engl J Med"},{"key":"10.1016\/j.lungcan.2009.03.031_bib10","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1016\/S0140-6736(94)90754-4","article-title":"The taxoids: paclitaxel and docetaxel","volume":"344","author":"Gelmon","year":"1994","journal-title":"Lancet"},{"key":"10.1016\/j.lungcan.2009.03.031_bib11","first-page":"4417","article-title":"Evaluation of the antitumor activity of gemcitabine (29,29-difluoro-29-deoxycytidine)","volume":"50","author":"Hertel","year":"1990","journal-title":"Cancer Res"},{"key":"10.1016\/j.lungcan.2009.03.031_bib12","first-page":"9","article-title":"Biochemical effects of navelbine on tubulin and associated proteins","volume":"16","author":"Fellous","year":"1989","journal-title":"Semin Oncol"},{"key":"10.1016\/j.lungcan.2009.03.031_bib13","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1200\/JCO.1994.12.2.360","article-title":"Randomized study of vinorelbine and cisplatin versus vindesine and cisplatin versus vinorelbine alone in advanced non-small-cell lung cancer: results of a European multicenter trial including 612 patients","volume":"12","author":"Le Chevalier","year":"1994","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.lungcan.2009.03.031_bib14","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1038\/sj.bjc.6600725","article-title":"CPT-11 Lung Cancer Study Group West. Randomised phase III trial of irinotecan combined with cisplatin for advanced non-small-cell lung cancer","volume":"88","author":"Negoro","year":"2003","journal-title":"Br J Cancer"},{"key":"10.1016\/j.lungcan.2009.03.031_bib15","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1093\/annonc\/mdi216","article-title":"Randomized phase III trial comparing cisplatin\u2013etoposide to carboplatin\u2013paclitaxel in advanced or metastatic non-small cell lung cancer","volume":"16","author":"Belani","year":"2005","journal-title":"Ann Oncol"},{"key":"10.1016\/j.lungcan.2009.03.031_bib16","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/S0169-5002(01)00493-7","article-title":"Gemcitabine (GEM) and carboplatin (CBDCA) versus cisplatin (CDDP) and vinblastine (VLB) in advanced non-small-cell lung cancer (NSCLC) stages III and IV: a phase III randomised trial","volume":"37","author":"Grigorescu","year":"2002","journal-title":"Lung Cancer"},{"key":"10.1016\/j.lungcan.2009.03.031_bib17","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1200\/JCO.2004.06.114","article-title":"Phase III randomized trial of docetaxel plus cisplatin versus vindesine plus cisplatin in patients with stage IV non-small-cell lung cancer: the Japanese Taxotere Lung Cancer Study Group","volume":"22","author":"Kubota","year":"2004","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.lungcan.2009.03.031_bib18","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1159\/000097944","article-title":"Persistent and aggressive treatment for thymic carcinoma. Results of a single-institute experience with 25 patients","volume":"70","author":"Maruyama","year":"2006","journal-title":"Oncology"},{"key":"10.1016\/j.lungcan.2009.03.031_bib19","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1093\/jnci\/92.3.179","article-title":"Will there be resistance to the RECIST (Response Evaluation Criteria in Solid Tumors)?","volume":"92","author":"Gehan","year":"2000","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.lungcan.2009.03.031_bib20","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1056\/NEJMoa011954","article-title":"Comparison of four chemotherapy regimens for advanced non-small-cell lung cancer","volume":"346","author":"Schiller","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1016\/j.lungcan.2009.03.031_bib21","doi-asserted-by":"crossref","first-page":"4285","DOI":"10.1200\/JCO.2002.02.068","article-title":"Phase III randomized trial comparing three platinum-based doublets in advanced non-small-cell lung cancer","volume":"20","author":"Scagliotti","year":"2002","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.lungcan.2009.03.031_bib22","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1093\/annonc\/mdl377","article-title":"Randomized phase III study of cisplatin plus irinotecan versus carboplatin plus paclitaxel, cisplatin plus gemcitabine, and cisplatin plus vinorelbine for advanced non-small-cell lung cancer: Four-Arm Cooperative Study in Japan","volume":"18","author":"Ohe","year":"2007","journal-title":"Ann Oncol"},{"key":"10.1016\/j.lungcan.2009.03.031_bib23","first-page":"4851","article-title":"Salvage chemotherapy with carboplatin and paclitaxel for cisplatin-resistant thymic carcinoma\u2014three cases","volume":"26","author":"Komatsu","year":"2006","journal-title":"Anticancer Res"},{"key":"10.1016\/j.lungcan.2009.03.031_bib24","doi-asserted-by":"crossref","DOI":"10.1200\/jco.2008.26.15_suppl.8018","article-title":"A phase II study of carboplatin plus paclitaxel in advanced thymoma and thymic carcinoma","volume":"26","author":"Lemma","year":"2008","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.lungcan.2009.03.031_bib25","series-title":"Atlas of tumor pathology. Tumors of the mediastinum","author":"Shimosato","year":"1997"}],"container-title":["Lung Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0169500209002104?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0169500209002104?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,5,17]],"date-time":"2020-05-17T23:38:02Z","timestamp":1589758682000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0169500209002104"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,2]]},"references-count":25,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2010,2]]}},"alternative-id":["S0169500209002104"],"URL":"https:\/\/doi.org\/10.1016\/j.lungcan.2009.03.031","relation":{},"ISSN":["0169-5002"],"issn-type":[{"value":"0169-5002","type":"print"}],"subject":[],"published":{"date-parts":[[2010,2]]}}}